Dark
Streaming/Mobile
Old Site
Home
Daily
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
14:44:45 EDT Fri 24 Mar 2023
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
News for U:IBIO from 2022-03-25 to 2023-03-24 - 17 items
News Releases
In The News
Other
CA
US
Date
Sym
Price
Type
Headline
2023-02-16 16:48
U
U:IBIO
News Release
200
iBio Announces MUC16 as its Latest Immune-Oncology Target Program
2023-01-05 08:00
U
U:IBIO
News Release
200
iBio Announces Issuance of U.S. Patent Covering AI-Engineered Epitope Discovery Engine
2022-12-09 16:05
U
U:IBIO
News Release
200
iBio Announces Closing of $3.5 Million Underwritten Public Offering
2022-12-06 23:28
U
U:IBIO
News Release
200
iBio Announces Pricing of $3.5 Million Underwritten Public Offering
2022-12-06 16:01
U
U:IBIO
News Release
200
iBio Announces Proposed Underwritten Public Offering
2022-12-06 08:00
U
U:IBIO
News Release
200
iBio to Participate in the JMP Securities Hematology and Oncology Summit
2022-12-05 08:00
U
U:IBIO
News Release
200
iBio ‚ ® to Showcase the RubrYc ‚ ® Discovery Engine During Poster Presentations at Antibody Engineering & Therapeutics Conference 2022
2022-12-02 16:30
U
U:IBIO
News Release
200
iBio Announces CEO Departure
2022-11-03 08:00
U
U:IBIO
News Release
200
iBio Accelerates Transformation to AI-Powered Biotech
2022-09-27 16:10
U
U:IBIO
News Release
200
iBio Reports Preliminary Unaudited Fiscal Year 2022 Financial Results and Provides Corporate Update
2022-09-21 08:30
U
U:IBIO
News Release
200
iBio Acquires RubrYc Therapeutics' AI Drug Discovery Platform and Pipeline
2022-08-16 09:00
U
U:IBIO
News Release
200
iBio Provides Update on Development of Next-Gen COVID-19 Vaccine Candidate
2022-05-18 08:00
U
U:IBIO
News Release
200
iBio to Participate in the H.C. Wainwright Global Investment Conference
2022-05-12 16:05
U
U:IBIO
News Release
200
iBio Reports Fiscal Third Quarter 2022 Financial Results and Provides Corporate Update
2022-05-09 08:00
U
U:IBIO
News Release
200
iBio Demonstrates Efficacy of an IL-2 Sparing Anti-CD25 Antibody Produced Using its FastPharming System for Treg Depletion in Cancer
2022-05-05 16:30
U
U:IBIO
News Release
200
iBio to Report Fiscal 2022 Third Quarter Financial Results and Provide Corporate Update on Thursday, May 12, 2022
2022-05-02 08:00
U
U:IBIO
News Release
200
iBio Announces Presentation Highlighting Superior Glycosylation for Antibodies Produced in Plants